Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $56.33 million. The enterprise value is $47.08 million.

Market Cap	56.33M
Enterprise Value	47.08M

Important Dates

The next estimated earnings date is Tuesday, March 25, 2025, before market open.

Earnings Date	Mar 25, 2025
Ex-Dividend Date	n/a

Share Statistics

GANX has 26.53 million shares outstanding. The number of shares has increased by 61.20% in one year.

Current Share Class	26.53M
Shares Outstanding	26.53M
Shares Change (YoY)	+61.20%
Shares Change (QoQ)	+38.07%
Owned by Insiders (%)	4.90%
Owned by Institutions (%)	7.49%
Float	25.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.41
P/TBV Ratio	6.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.09.

Current Ratio	2.99
Quick Ratio	2.70
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -263.14% and return on invested capital (ROIC) is -148.44%.

Return on Equity (ROE)	-263.14%
Return on Assets (ROA)	-94.13%
Return on Invested Capital (ROIC)	-148.44%
Return on Capital Employed (ROCE)	-219.35%
Revenue Per Employee	n/a
Profits Per Employee	-$667,717
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $46,579 in taxes.

Income Tax	46,579
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.75% in the last 52 weeks. The beta is 0.14, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	-51.75%
50-Day Moving Average	2.22
200-Day Moving Average	1.81
Relative Strength Index (RSI)	53.71
Average Volume (20 Days)	245,683

Short Selling Information

The latest short interest is 462,159, so 1.74% of the outstanding shares have been sold short.

Short Interest	462,159
Short Previous Month	365,119
Short % of Shares Out	1.74%
Short % of Float	1.83%
Short Ratio (days to cover)	1.44

Income Statement

Revenue	n/a
Gross Profit	-11.46M
Operating Income	-21.43M
Pretax Income	-21.54M
Net Income	-21.37M
EBITDA	-21.39M
EBIT	-21.43M
Earnings Per Share (EPS)	-$1.08

Full Income Statement

Balance Sheet

The company has $12.05 million in cash and $769,413 in debt, giving a net cash position of $11.28 million or $0.43 per share.

Cash & Cash Equivalents	12.05M
Total Debt	769,413
Net Cash	11.28M
Net Cash Per Share	$0.43
Equity (Book Value)	8.91M
Book Value Per Share	0.34
Working Capital	9.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.08 million and capital expenditures -$21,567, giving a free cash flow of -$21.10 million.

Operating Cash Flow	-21.08M
Capital Expenditures	-21,567
Free Cash Flow	-21.10M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.20%
Shareholder Yield	-61.20%
Earnings Yield	-36.62%
FCF Yield	-36.16%

Analyst Forecast

The average price target for GANX is $8.33, which is 292.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.33
Price Target Difference	292.24%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	172.08%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GANX has an Altman Z-Score of -6.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.69
Piotroski F-Score	3